Keith Pitts - Feb 7, 2022 Form 4/A - Amendment Insider Report for MARRONE BIO INNOVATIONS INC (MBII)

Role
SVP & Chief Sust. Officer
Signature
/s/ Linda V. Moore, as attorney in fact
Stock symbol
MBII
Transactions as of
Feb 7, 2022
Transactions value $
$68,464
Form type
4/A - Amendment
Date filed
3/18/2022, 05:40 PM
Date Of Original Report
Feb 9, 2022
Previous filing
May 27, 2021
Next filing
Jul 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBII Common Stock Award $68.5K +108K +2276.9% $0.63 113K Feb 7, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBII Stock Option (Right to Buy) Award $0 +253K $0.00 253K Feb 7, 2022 Common Stock 253K $0.63 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 7, the reporting person was granted 108,312 restricted stock units, which represent a contingent right to receive one share of Issuer's common stock. The restricted stock units vest pursuant to the Vesting Schedule (as defined in footnote (2)) and are delivered to the reporting person upon vesting.
F2 The awards vest in equal monthly installments over three years, subject to the recipient's continued employment by the Issuer through the applicable vesting date, provided that, in lieu of the terms of any change in control agreement in place between the Issuer and the reporting person, in the event that the reporting person resigns for Good Reason (as defined in the recipient's change in control agreement) or is terminated without Cause (as defined in recipient's change in control agreement) within twelve months of a Change in Control (as defined in recipient's change in control agreement), 50% of the unvested portion of the awards will become immediately vested (the "Vesting Schedule").
F3 The original Form 4, filed on February 9, 2022, is being amended by this Form 4 amendment solely to correct an administrative error, which misstated the expiration date as February 6, 2025.